INTERNATIONAL PATENT: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD., HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. FILES APPLICATION FOR "METHODS OF CANCER DETECTION BY DISCORDANT METHYLATION IN CFDNA"

GENEVA, Oct. 6 -- YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Hi-Tech Park, Edmond J. Safra CampusGivat Ram, P.O.B. 3913591390 Jerusalem), HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. (Jerusalem BioPark, Hadassah Ein Kerem Medical CenterP.O.B. 120009112001 Jerusalem) filed a patent application (PCT/IL2025/050282) for "METHODS OF CANCER DETECTION BY DISCORDANT METHYLATION IN CFDNA" on Mar 26, 2025. With publication no. WO/2025/203031, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s...